全球糖尿病危机加剧：中国未确诊患者达7300万，健康警报亟待关注

Core Viewpoint - The article highlights the alarming rise in global diabetes prevalence, with over 800 million adults affected, and emphasizes the urgent need for improved public health strategies and early intervention, particularly in high-risk populations like China [5][9][10]. Group 1: Global Diabetes Trends - The total number of global adult diabetes patients has surpassed 800 million, a fourfold increase since 1990, with 4.45 million untreated patients aged 30 and above in 2022 [5][9]. - By 2050, global diabetes patients are projected to exceed 1.31 billion, indicating a significant public health challenge ahead [7]. - The global diabetes prevalence rate increased by 90.5% from 1990 to 2021, rising from 3.2% to 6.1% [7]. Group 2: Diabetes in China - China has 148 million diabetes patients, ranking second globally, with over 52% of these patients untreated [9][10]. - The majority of new diabetes cases in China are type 2 diabetes, accounting for 99.2% of new cases in 2021 [10]. - The gender disparity in diabetes-related health burdens is notable, with men experiencing a higher disability burden compared to women [10]. Group 3: Complications and Healthcare Burden - Approximately 30% to 40% of diabetes patients may develop chronic kidney disease (CKD), with type 2 diabetes being a major contributing factor [8]. - The number of new CKD cases due to type 2 diabetes rose from 1.4 million in 1990 to 2.4 million in 2017, a 74% increase [8]. - The treatment resources for end-stage kidney disease (ESKD) are unevenly distributed globally, with only 27% to 53% of patients receiving necessary care [8]. Group 4: Prevention and Control Strategies - The updated "China Diabetes Prevention and Control Guidelines (2024)" indicates a continuous rise in diabetes prevalence, necessitating enhanced screening and diagnostic measures [11][12]. - The national health initiative aims to increase diabetes awareness and screening rates, targeting a 60% awareness rate among adults by 2030 [12][13]. - The guidelines emphasize the importance of regular blood sugar testing for high-risk groups and the need for improved healthcare capabilities at the grassroots level [12][13].